Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Stock Short Interest Report for October

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a significant growth in short interest in October. As of October 30th, there was short interest totaling 124,174 shares, a growth of 3,213.1% from the October 15th total of 3,748 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 1,427,500 shares, the short-interest ratio is presently 0.1 days.

Advanced Medical Isotope Stock Performance

RDGL stock traded up $0.00 during midday trading on Tuesday, hitting $0.04. The company’s stock had a trading volume of 84,085 shares, compared to its average volume of 603,227. Advanced Medical Isotope has a 12 month low of $0.04 and a 12 month high of $0.12. The firm’s 50-day moving average is $0.05 and its 200-day moving average is $0.06.

Advanced Medical Isotope Company Profile

Advanced Medical Isotope Corp. (OTCMKTS:RDGL) is a medical technology company developing isotope-based treatments for cancer and other localized medical conditions. Its work centers on targeted radiation therapies designed to deliver radioactive material directly to tumors while limiting exposure to surrounding healthy tissue. The company’s principal product platform is Radiogel, an injectable, biodegradable gel intended to deliver therapeutic radioisotopes locally within solid tumors. Advanced Medical Isotope has also developed IsoPet, a related isotope-based treatment for certain cancers in companion animals.